Covidien Ltd. (NYSE:COV)

CAPS Rating: 5 out of 5

The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.


Player Avatar TMFDeej (99.24) Submitted: 12/15/2011 7:31:35 PM : Outperform Start Price: $42.03 COV Score: +48.26

Covidien is a company that I've had my eye on for a while, ever since it was spun off from Tyco. It hasn't done much but bounce around since then. It just announced that it plans to split its medical device and pharma businesses. I like the move.Deej

Featured Broker Partners